Movement Alert|Principal Rises 7.36% in Regular Trading, Multiple Investment Banks Raise Target Prices Amid Sector Strength

Market Focus09-04

On September 3, Principal rose 7.36% in regular trading, trading at $118.66/share, with turnover of $188 million. The rally was driven by a wave of target price upgrades from multiple investment banks, compounded by broader strength in the life and health insurance sector.

On the news front, Keefe, Bruyette & Woods raised its price target on Principal to $117 from $112, maintaining a Market Perform rating, while Raymond James lifted its target to $121 from $111, keeping an Outperform rating. JPMorgan and Morgan Stanley also adjusted their targets upward in recent months. Fundamentally, the company reported Q2 adjusted EPS of $2.50, a 15.74% year-over-year increase that beat the consensus estimate of $2.34. The quarterly dividend was raised to $0.84 per share, and assets under management reached $808 billion as of June 30. Additionally, the company announced the acquisition of employee benefits firm Beam Benefits, expanding its business footprint while reaffirming full-year capital deployment and EPS growth targets.

At the sector level, the Life & Health Insurance industry showed broad strength, with Prudential up 2.75%, Lincoln National up 2.50%, MetLife up 2.32%, and Oscar Health up 4.01%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment